United States 119th Congress Status: In Committee Bipartisan · 5 R · 4 D cosponsors

HR 3789 — DTC Act of 2025

Last action — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced June 05, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 42% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 9 sponsors

    1 primary, 8 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (5 R · 4 D) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Bill Text

How this bill changes current law

8 changes Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill requires direct-to-consumer advertisements for prescription drugs and biological products to disclose pricing information.

  • Part A of title XI of the Social Security Act

    SEC. 1150D. REQUIREMENT THAT DIRECT-TO-CONSUMER ADVERTISEMENTS FOR PRESCRIPTION DRUGS AND BIOLOGICALS INCLUDE AN APPROPRIATE DISCLOSURE OF PRICING INFORMATION.

    This adds a new section requiring price disclosure in advertisements.

  • Part A of title XI of the Social Security Act

    (a) Requirement.--(1) In general.--Subject to paragraph (2), not later than July 1, 2026, the Secretary shall require that each direct-to-consumer advertisement for a prescription drug or biological product... also include an appropriate disclosure of pricing information, as described in subsection (b)

    Establishes a deadline and requirement for price disclosure in drug advertisements.

  • Part A of title XI of the Social Security Act

    (2) Exemption.--The requirement under paragraph (1) shall not apply to a prescription drug or biological product for which the wholesale acquisition cost for a 30-day supply... is less than $35.

    Exempts low-cost drugs from the price disclosure requirement.

  • Part A of title XI of the Social Security Act

    (b) Appropriate Disclosure of Pricing Information.--For the purposes of subsection (a), an appropriate disclosure of pricing information... shall clearly and conspicuously disclose the wholesale acquisition cost for a 30-day supply...

    Specifies how pricing information must be disclosed in advertisements.

  • Part A of title XI of the Social Security Act

    (c) Rulemaking.--Not later than 1 year after the date of enactment of this section, the Secretary shall promulgate final regulations...

    Mandates the Secretary to create regulations for compliance.

  • Part A of title XI of the Social Security Act

    (d) Sanctions.--Any manufacturer... that violates the requirement of this section may be subject to a civil money penalty of not more than $100,000 for each such violation.

    Imposes penalties for non-compliance with the new advertisement requirements.

  • Part A of title XI of the Social Security Act

    (e) Public Reporting.--... the Secretary may use information reported about manufacturers that fail to comply with such requirement.

    Allows the Secretary to publicly report manufacturers who do not comply.

  • Part A of title XI of the Social Security Act

    (f) Definitions.--In this section: (1) Biological product.--The term `biological product' means any biological product (as defined in section 351(i) of the Public Health Service Act)...

    Defines 'biological product' for clarity in the context of the law.

Action History

  1. Introduced in House

  2. Introduced in House

  3. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 8 co-sponsors · 538 not signed on

Sponsors (1)

Co-sponsors (8)

Not signed on (538)

538 members have not signed on to this bill.

Show all 538 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

taxation healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 3789 do?
Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Who sponsors HR 3789?
HR 3789 is sponsored by Schakowsky, Janice D. (Democratic), Begich, Nicholas J. (Republican), Quigley, Mike (Democratic), Bresnahan, Robert P. (Republican), Norton, Eleanor Holmes (Democratic), Nunn, Zachary (Republican), Vindman, Eugene Simon (Democratic), Hinson, Ashley (Republican), and Taylor, David J. (Republican).
What is the current status of HR 3789?
This bill is in committee in the House. Introduced June 05, 2025. It must pass committee before a floor vote.
Where can I track HR 3789?
Track HR 3789 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 3789

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 3789

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →